
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Dysplastic nevus laboratory tests
Introduction
Overview
Overview
There are no laboratory findings associated with the diagnosis of melanoma. Serum lactate dehydrogenase (LDH) may be elevated among patients with metastasis.
Laboratory Findings
Laboratory Findings
- There are no laboratory findings associated with the diagnosis of melanoma. Measurement of serum LDH may be considered for follow-up among patients who have been diagnosed with stage IB-IV melanoma.[1]
Lactate Dehydrogenase (LDH)
- Once metastatic melanoma is diagnosed, serum lactate dehydrogenase (LDH) may be helpful for follow-up.[1]
- For patients with stage IB-IV melanoma, measurement of serum LDH may be considered every 6-12 months.[1]
Diagnosis
Diagnosis
The following algorithm illustrates the approach to patients with suspected melanoma.[1]
 |  |  |  |  |  |  |  | Suspicious pigmented lesion |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||||
 |  |  |  |  |  |  |  | Biopsy |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||
 |  |  |  |  |  | ||||||||||||||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  | Inadequate |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  | Rebiopsy |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||
 |  |  |  |  |  | ||||||||||||||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  | Melanoma confirmed |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||
Breslow thickness |  | Ulceration status |  | Mitotic rate |  | Depth and peripheral margin status |  | Presence of satellitosis |  | Clark level for lesions ≤ 1 mm | |||||||||||||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||||
 |  |  |  |  |  |  |  | Reassessment with complete physical examination, including neurological exam and lymph node assessment |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | |||||||||||||||||||||||
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ||||||||||||||||||||||||||||
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Â ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
